Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Study results from T.A. Kokjohn and colleagues update understanding of immunization
June 3rd, 2009
According to a study from the United States, "Post mortem examinations of AN-1792-vaccinated humans revealed this therapy produced focal senile plaque disruption. Despite the dispersal of substantial plaque material, vaccination did not constitute even a partial eradication of brain amyloid as water soluble amyloid-beta (A beta) 40/42 increased in the gray matter compared to sporadic Alzheimer's disease (AD) patients and total brain A beta levels were not decreased." "Significant aspects of AD pathology were unaffected by vaccination with both vascular amyloid and hyper-phosphorylated tau deposits appeared refractory to this therapy. In addition, vaccination resulted in...
Source: Vaccine Weekly (2009-06-03)
|
